Pompe India > News > Uncertainty for Masterton mother after drug trial ditched

Uncertainty for Masterton mother after drug trial ditched

Masterton mother of three Allyson Lock is one of 11 kiwis with Pompe disease, a rare and incurable degenerative disorder. The drug trial she has been on for the past five years has been abruptly cancelled. Photo / Hayley Gastmeier

Masterton mother of three Allyson Lock is one of 11 kiwis with Pompe disease, a rare and incurable degenerative disorder. The drug trial she has been on for the past five years has been abruptly cancelled. Photo / Hayley Gastmeier

In a few weeks’ time, Allyson Lock’s fate will be left “swinging in the wind”.

The Masterton mother of three has Pompe disease, a rare inherited degenerative disorder which is almost always fatal.

For the past five years Mrs Lock, 51, has been on a drug trial run by pharmaceutical giant BioMarin.

“The drug was giving me my life back,” she said.

But last week she found out the trial had been canned.

“It halted the progression of the fatal disease, so without it I will die.

Click here to read more.

 

Highslide for Wordpress Plugin